Practical News: AI & Business News

Latest Episodes:

GPT-4: The Education Disruptor - How Your Personal Tutor Just Got Smarter Jan 23, 2024

Show notes

In this episode, explore the groundbreaking role of GPT-4 in disrupting education, as we delve into how this advanced AI model is becoming your personal tutor, revolutionizing the learning experience with unprecedented intelligence and adaptability.

Invest in AI Box: https://Republic.com/ai-box
Get on the AI Box Waitlist: ⁠⁠https://AIBox.ai/⁠⁠
AI Facebook Community
Learn more about AI in Music
Learn more about AI Models

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

ChatGPT Integration Masterclass: Boost Your Business, Project, or Career with Expert Insights Jan 23, 2024

Show notes

In this episode, learn the art of seamlessly integrating ChatGPT into your business, project, or career as we explore real-world examples, including the innovative applications of Einstein GPT, ZillowGPT, and Upwork AI.

Invest in AI Box: https://Republic.com/ai-box
Get on the AI Box Waitlist: ⁠⁠https://AIBox.ai/⁠⁠
AI Facebook Community
Learn more about AI in Music
Learn more about AI Models

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

GenAI Marketing Unleashed: Typeface, GrowthLoop, and Google Cloud Join Forces in Groundbreaking Partnership Jan 23, 2024

Show notes

In this episode, we dive into the exciting collaboration between Typeface, GrowthLoop, and Google Cloud, exploring the launch of their revolutionary GenAI Marketing Solution and the transformative impact it promises to have on the marketing landscape.

Invest in AI Box: https://Republic.com/ai-box
Get on the AI Box Waitlist: ⁠⁠https://AIBox.ai/⁠⁠
AI Facebook Community
Learn more about AI in Music
Learn more about AI Models

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

AI21 Labs' Game-Changing Boost: $155M Funding Fuels Enterprise Generative AI Jan 23, 2024

Show notes

In this episode, we explore the groundbreaking developments as AI21 Labs secures an impressive $155 million in funding, propelling the advancement of their enterprise generative AI technologies and reshaping the landscape of artificial intelligence.

Invest in AI Box: https://Republic.com/ai-box
Get on the AI Box Waitlist: ⁠⁠https://AIBox.ai/⁠⁠
AI Facebook Community
Learn more about AI in Music
Learn more about AI Models

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Empowering Educators: OpenAI's Custom ChatGPT Prompts for Innovative Teaching Jan 23, 2024

Show notes

In this episode, we explore how OpenAI is providing educators with tailor-made ChatGPT prompts, delving into the unique use cases and inventive ways teachers are leveraging this tool to enhance the learning experience for students.

Invest in AI Box: https://Republic.com/ai-box
Get on the AI Box Waitlist: ⁠⁠https://AIBox.ai/⁠⁠
AI Facebook Community
Learn more about AI in Music
Learn more about AI Models

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Navigating Tomorrow's Data Landscape: A Conversation with Kelly Cherniwchan, CEO of Chata.ai Jan 23, 2024

Show notes

In this episode, we sit down with Kelly Cherniwchan, CEO of Chata.ai, to explore the future of artificial intelligence in business analytics, gaining insights into how emerging technologies are reshaping the way organizations analyze and leverage data.

Invest in AI Box: https://Republic.com/ai-box
Get on the AI Box Waitlist: ⁠⁠https://AIBox.ai/⁠⁠
AI Facebook Community
Learn more about AI in Music
Learn more about AI Models

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Tech Trade Turmoil: U.S. Imposes Limits on Nvidia and AMD AI Chip Exports to the Middle East Jan 23, 2024

Show notes

In this episode, we delve into the recent developments in the tech world, analyzing the implications of the U.S. decision to restrict the export of AI chips from industry giants Nvidia and AMD to the Middle East.

Invest in AI Box: https://Republic.com/ai-box
Get on the AI Box Waitlist: ⁠⁠https://AIBox.ai/⁠⁠
AI Facebook Community
Learn more about AI in Music
Learn more about AI Models

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Baidu's AI Breakthrough, IBM's Love for Salesforce, .ai Nets $30M, and X's New Policy Jan 23, 2024

Show notes

In this episode, we unpack the latest in the AI world, from Baidu's groundbreaking advancements to the intriguing alliance between IBM and Salesforce, the significant $30 million funding secured by .ai, and the unveiling of X's transformative new policy.

Invest in AI Box: https://Republic.com/ai-box
Get on the AI Box Waitlist: ⁠⁠https://AIBox.ai/⁠⁠
AI Facebook Community
Learn more about AI in Music
Learn more about AI Models

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

AI's Next Frontier: A Conversation with Paula Phelan, COO of Intelligent Relations Jan 23, 2024

Show notes

In this episode, we sit down with Paula Phelan, Chief Operating Officer of Intelligent Relations, to explore the unfolding landscape of artificial intelligence in public relations, discussing key insights and future possibilities.

Invest in AI Box: https://Republic.com/ai-box
Get on the AI Box Waitlist: ⁠⁠https://AIBox.ai/⁠⁠
AI Facebook Community
Learn more about AI in Music
Learn more about AI Models

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

QuantHealth Secures $15M for AI-Driven Advancements in US Clinical Drug Trials Jan 23, 2024

Show notes

In this episode, we delve into the details of QuantHealth's recent $15 million funding success, examining how their innovative use of artificial intelligence is set to revolutionize the landscape of clinical drug trials in the United States.